Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CDCP1 Mouse anti-Human, Biotin, Clone: OTI4F1, liquid, TrueMAB™
SDP

Mouse Monoclonal Antibody

Supplier:  OriGene TA700037

Encompass_Preferred

Catalog No. 50-167-7595


May include imposed supplier surcharges.
Only null left
Add to Cart

Description

Description

CDCP1 is a transmembrane protein containing three extracellular CUB domains. It is found to be overexpressed in colon and lung cancers. Its expression level is correlated with the metastatic ability of carcinoma cells. CDCP1 is located on the cell surface. It has been shown to be tyrosine phosphorylated in a cancer cell line. Alternatively spliced transcript variants encoding distinct isoforms have been reported.
Specifications

Specifications

CDCP1
Monoclonal
0.5 mg/mL
PBS with 10mg/ml BSA, 50% glycerol and 0.05% sodium azide
Q9H5V8
CDCP1
Full length human recombit protein of human CDCP1 produced in HEK293T cell.
50 μg
Primary
Human
Antibody
IgG1
ELISA
OTI4F1
Biotin
CDCP1
CD318, SIMA135, TRASK
Mouse
Affinity Chromatography
RUO
64866
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.